Although this center is supported by branches that refer to complex surgical cases, including breast cancer, the final cohort used for analysis was relatively small (N=3577), and the exclusion of certain patient groups (such as those with HER2 overexpression) may have impacted the generalizability of our results. This evidence concerns the gene ERBB2 and breast carcinoma.